CorMedix Inc.
CRMD
$6.30
$0.233.79%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 31.21M | 11.46M | 806.10K | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 31.21M | 11.46M | 806.10K | -- | -- |
| Cost of Revenue | 1.18M | 686.60K | 509.80K | 818.50K | -- |
| Gross Profit | 30.03M | 10.77M | 296.30K | -818.50K | -- |
| SG&A Expenses | 15.37M | 13.33M | 14.95M | 15.05M | 13.38M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 18.27M | 14.74M | 16.11M | 16.70M | 15.67M |
| Operating Income | 12.94M | -3.29M | -15.30M | -16.70M | -15.67M |
| Income Before Tax | 13.46M | -2.78M | -14.15M | -15.86M | -14.75M |
| Income Tax Expenses | 0.00 | -- | -- | -1.39M | -- |
| Earnings from Continuing Operations | 13.46M | -2.78M | -14.15M | -14.47M | -14.75M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 13.46M | -2.78M | -14.15M | -14.47M | -14.75M |
| EBIT | 12.94M | -3.29M | -15.30M | -16.70M | -15.67M |
| EBITDA | 13.07M | -3.21M | -15.22M | -16.68M | -15.65M |
| EPS Basic | 0.22 | -0.05 | -0.25 | -0.25 | -0.26 |
| Normalized Basic EPS | 0.14 | -0.03 | -0.15 | -0.17 | -0.16 |
| EPS Diluted | 0.22 | -0.05 | -0.25 | -0.25 | -0.26 |
| Normalized Diluted EPS | 0.14 | -0.03 | -0.15 | -0.17 | -0.16 |
| Average Basic Shares Outstanding | 61.51M | 58.83M | 57.62M | 57.50M | 57.39M |
| Average Diluted Shares Outstanding | 61.51M | 58.83M | 57.62M | 57.50M | 57.39M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
